82 related articles for article (PubMed ID: 8743526)
1. Antihypertensive activity and renal effects of benazepril in humans.
Tramonti G; Donadio C; Confessore N; Bianchi C
Kidney Int Suppl; 1996 Jun; 55():S107-8. PubMed ID: 8743526
[TBL] [Abstract][Full Text] [Related]
2. Renal effects of prolonged antihypertensive treatment with diltiazem.
Tramonti G; Donadio C; Silvestri L; Caputo M; Lucchetti A; Giordani R; Bianchi C
Kidney Int Suppl; 1996 Jun; 55():S78-80. PubMed ID: 8743517
[TBL] [Abstract][Full Text] [Related]
3. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
4. Effects of valsartan with or without benazepril on blood pressure, angiotensin II, and endoxin in patients with essential hypertension.
Ke YS; Tao YY; Yang H; Yu GH
Acta Pharmacol Sin; 2003 Apr; 24(4):337-41. PubMed ID: 12676074
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
Ol'binskaia LI; Golubev SA; Morozova TE
Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
[TBL] [Abstract][Full Text] [Related]
6. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
Chrysant SG; Bakris GL
Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
[TBL] [Abstract][Full Text] [Related]
7. An open clinical trial of benazepril--a new ACE inhibitor in mild-moderate hypertension.
Karnik ND; Oza YK; Sane SP; Kaushik R; Bhatt AD; Chawla KP; Vaidya AB; Yajnik VH; Khokhani RC
J Assoc Physicians India; 1998 Mar; 46(3):283-5. PubMed ID: 11273348
[TBL] [Abstract][Full Text] [Related]
8. Effect of benazepril monotherapy in subjects with hypertension associated with renal dysfunction.
Reams GP; Lau A; Bauer JH
J Clin Pharmacol; 1989 Jul; 29(7):609-14. PubMed ID: 2668351
[TBL] [Abstract][Full Text] [Related]
9. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
11. Influence of benazepril and captopril on blood pressure, glucocorticoids and progesterone in essential hypertensives.
Olbinskaya LI; Golubev SA; Bolshakova TD
J Hum Hypertens; 1993 Dec; 7(6):603-6. PubMed ID: 8114057
[TBL] [Abstract][Full Text] [Related]
12. Effects of benazepril on insulin resistance and glucose tolerance in uremia.
Wu Z; Bao X
Clin Nephrol; 1998 Aug; 50(2):108-12. PubMed ID: 9725782
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Kanno Y; Okada H; Saruta T; Suzuki H
Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
[TBL] [Abstract][Full Text] [Related]
14. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
Almenar L; Osa A; Palencia M; Flores A; Sánchez E
J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation on the effect of Benazepril for hypertension through postmarketing surveillance].
Cao W; Li L; Hu Y; Zhan S; Li X; Li P; Wu T; Li J; Wang T
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Jun; 21(3):190-3. PubMed ID: 11860782
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
Rosolová H; Cech J; Sefrna F
Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
[TBL] [Abstract][Full Text] [Related]
17. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of benazepril after failure of the first antihypertensive treatment].
Francillon A; Heintzmann F; Serrurier D
Therapie; 1994; 49(2):95-9. PubMed ID: 7817356
[TBL] [Abstract][Full Text] [Related]
19. [The effects of treatment with atenolol and benazapril on 24-hour pressure variability].
Prattichizzo FA; Galetta F
Minerva Cardioangiol; 1993 Dec; 41(12):587-90. PubMed ID: 8139779
[TBL] [Abstract][Full Text] [Related]
20. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
